EXHIBIT 10.26 PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT UNDER RULE 24(B)-2. THE LOCATION OF THOSE OMITTED PORTIONS IS DENOTED BY BRACKETS. DEVELOPMENT AND...Development and License Agreement • March 31st, 1999 • Autoimmune Inc • Biological products, (no disgnostic substances) • New York
BACKGROUND ----------Lease • March 31st, 1999 • Autoimmune Inc • Biological products, (no disgnostic substances)
AGREEMENT ---------Sublease Termination Agreement • March 31st, 1999 • Autoimmune Inc • Biological products, (no disgnostic substances)
